REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS

被引:2
|
作者
Madarati, Hasam
Singh, Kanwal
Sparring, Taylor
Andrisani, Peter
Liaw, Patricia C.
Fox-Robichaud, Alison E.
Kretz, Colin A.
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
来源
SHOCK | 2024年 / 61卷 / 02期
关键词
ADAMTS13; Von Willebrand factor; sepsis; disseminated intravascular coagulation; hemostasis; coagulation; cardiovascular disease; thrombotic microangiopathies; thrombotic thrombocytopenia purpura; Von Willebrand disease; inflammation; neutrophil extracellular traps; alpha-defensin; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; INTRAVASCULAR COAGULATION; INFLAMMATORY CYTOKINES; CLINICAL-IMPLICATIONS; ENDOTHELIAL-CELLS; FACTOR PROPEPTIDE;
D O I
10.1097/SHK.0000000000002291
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Sepsis is defined as a life-threatening organ dysfunction caused by excessive host response to infection, and represents the most common cause of in-hospital deaths. Sepsis accounts for 30% of all critically ill patients in the intensive care unit (ICU), and has a global mortality rate of 20%. Activation of blood coagulation during sepsis and septic shock can lead to disseminated intravascular coagulation, which is characterized by microvascular thrombosis. Von Willebrand factor (VWF) and ADAMTS13 are two important regulators of blood coagulation that may be important links between sepsis and mortality in the ICU. Herein we review our current understanding of VWF and ADAMTS13 in sepsis and other critical illnesses and discuss their contribution to disease pathophysiology, their use as markers of severe illness, and potential targets for new therapeutic development.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 50 条
  • [41] Optimization of the detection of inhibitory autoantibodies against the VWF-cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay
    Jacquemin, Marc
    Van Horenbeeck, Isa
    Debasse, Mirjam
    Toelen, Jelle
    Schoeters, Joke
    Vanlinthout, Ingrid
    Peerlinck, Kathelijne
    Dierickx, Daan
    Van Laer, Christine
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : 290 - 297
  • [42] ADAMTS13 in von Willebrand factor (VWF) concentrates: is an intact VWF triplet structure important for VWF function?
    Fuchs, B.
    Solecka, B.
    Kroening, M.
    Kannicht, C.
    HAEMOPHILIA, 2012, 18 : 43 - 43
  • [43] The ADAMTS13 content in commercially available VWF/FVIII concentrates correlates with their VWF triplet structure
    Kannicht, S.
    Gruber, G.
    Stadler, M.
    Pock, K.
    Svae, T.
    Roemisch, J.
    HAEMOPHILIA, 2008, 14 : 114 - 114
  • [44] Detection of ADAMTS13 activity using the native VWF91 peptide
    Bai, X.
    Su, J.
    Cao, L.
    Yu, Z.
    Wang, Z.
    Ruan, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 767 - 768
  • [45] Comparison of thrombomodulin, vWF, and ADAMTS13 levels between preeclampsia and normal pregnancy
    Ahmad, Aisha
    Mustafa, Ghulam
    Mazari, Nazish
    Naveed, Muhammad Asif
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (01) : 38 - 42
  • [46] Influence of the von willebrand factor VWF substrate on ADAMTS13 activity measurement
    Palla, R.
    Valsecchi, C.
    Spreafico, M.
    Bajetta, M. T.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 253 - 254
  • [47] FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
    Kokame, K
    Nobe, Y
    Kokubo, Y
    Okayama, A
    Miyata, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) : 93 - 100
  • [48] The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis
    de Groot, Rens
    Lane, David A.
    Crawley, James T. B.
    BLOOD, 2015, 125 (12) : 1968 - 1975
  • [49] The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis
    Chauhan, Anil K.
    Walsh, Meghan T.
    Zhu, Guojing
    Ginsburg, David
    Wagner, Denisa D.
    Motto, David G.
    BLOOD, 2008, 111 (07) : 3452 - 3457
  • [50] vWF及ADAMTS13在肝脏疾病中的意义
    陈亚利
    许姗姗
    张晶
    肝脏, 2016, 21 (04) : 316 - 319